Tingyue Wu
机构:University of Science and Technology of China, Kunming Institute of Zoology, Chinese Academy of Sciences, University of Hong Kong
发表论文 6 篇 · 总被引 89 次 · h-index 6
代表论文
- Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer (2024 · Journal of Experimental & Clinical Cancer Research · 被引 32)
- 5-Hydroxymethylfurfural Enhances the Antiviral Immune Response in Macrophages through the Modulation of RIG-I-Mediated Interferon Production and the JAK/STAT Signaling Pathway (2021 · ACS Omega · 被引 21)
- CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer (2024 · Biomedicine & Pharmacotherapy · 被引 13)
- An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesis (2024 · Journal of Advanced Research · 被引 9)
- Toxoflavin analog D43 exerts antiproliferative effects on breast cancer by inducing ROS-mediated apoptosis and DNA damage (2024 · Scientific Reports · 被引 7)
- Elf4 regulates lysosomal biogenesis and the mTOR pathway to promote clearance of Staphylococcus aureus in macrophages (2021 · FEBS Letters · 被引 7)